Novo Nordisk stock has been pretty volatile lately, making it hard to judge whether now is a good opportunity to buy shares.
A Scandinavian economic behemoth, Novo Nordisk is the highest valued company in Europe at over $500 billion, which ...
Readouts from Novo Nordisk and Viking Therapeutics at AASLD 2024 strengthen the argument for GLP-1 therapies as an emerging ...
Novo Nordisk's Wegovy launch in China begins in Shanghai at $194 per four-injection pack, significantly cheaper than ...
The company narrowed its full-year guidance as its blockbuster weight-loss drug soars in popularity.
Sales of Wegovy were 79% higher in the third quarter of 2024 compared to the same time period a year earlier, Novo Nordisk said. Novo Nordisk on Wednesday reported a third-quarter beat on ...
Danish pharmaceutical giant Novo Nordisk has introduced its weight loss drug, Wegovy, to the Chinese market. The launch, confirmed by the company via Reuters and first reported by Chinese business ...
Merck reported that a new formulation of Keytruda appears to deliver similar blood levels of the drug when given as a shot as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback